Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 HKD | -2.14% | -2.14% | -6.16% |
03/04 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
03/04 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |